Use of Sirolimus in the Treatment of Refractory Autoimmune Hepatitis

Heneghan, 2002, Current and novel immunosuppressive therapy for autoimmune hepatitis, Hepatology, 35, 7, 10.1053/jhep.2002.30991 Boberg, 1998, Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population, Scand J Gastroenterol, 33, 99, 10.1080/00365529850166284 Richardson, 2000, Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine, J Hepatol, 33, 371, 10.1016/S0168-8278(00)80271-8 Czaja, 2012, Advances in the current treatment of autoimmune hepatitis, Dig Dis Sci, 57, 1996, 10.1007/s10620-012-2151-2 Chan, 2004, Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer, Br J Cancer, 91, 1420, 10.1038/sj.bjc.6602162 Manns, 2010, Diagnosis and management of autoimmune hepatitis, Hepatology, 51, 2193, 10.1002/hep.23584 Kerkar, 2005, Rapamycin successfully treats post-transplant autoimmune hepatitis, Am J Transplant, 5, 1085, 10.1111/j.1600-6143.2005.00801.x Kurowski, 2014, Sirolimus as rescue therapy in pediatric autoimmune hepatitis, J Pediatr Gastroenterol Nutr, 58, e4, 10.1097/MPG.0b013e318291feaa Fernandes, 1999, Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis, Am J Gastroenterol, 94, 241, 10.1111/j.1572-0241.1999.00807.x Van Thiel, 1995, Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial, Am J Gastroenterol, 90, 771 Aqel, 2004, Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis, J Clin Gastroenterol, 38, 805, 10.1097/01.mcg.0000139050.67178.be Larsen, 2007, Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis, World J Gastroenterol, 13, 3232, 10.3748/wjg.v13.i23.3232 Chatur, 2005, Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus, Liver Int, 25, 723, 10.1111/j.1478-3231.2005.01107.x Tannous, 2011, Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience, Aliment Pharmacol Ther, 34, 405, 10.1111/j.1365-2036.2011.04749.x